Preferences
Related Series
Related Segments


EHR Clinical Optimization 2025
Which Firms Are Best Positioned to Help Organizations Realize Their EHR’s Full Potential?
Healthcare organizations continue to heavily invest in their EHRs to enhance care delivery, reduce clinician burdens, streamline documentation, and meet regulatory compliance. However, many still struggle to fully realize these benefits amid operational challenges and mounting administrative demands, frequently leaving clinicians wanting more from their EHRs as they experience dissatisfaction and burnout (see callout below). Thus, organizations are increasingly seeking support from services firms to optimize their EHR technology and associated workflows—a trend reflected in the steady growth of validated engagements since 2018. To help organizations identify the firm best suited to their needs in a high-performing market, this report explores (1) key drivers of client satisfaction and firm-specific strengths, (2) validated engagement types and areas of expertise, and (3) common pitfalls of and best practices for clinical optimization projects.
If you don't have a login, getting started is easy.
Key Findings:
- Nordic & Chartis Drive Strong Client Experience by Providing Deep Expertise & Strategic Partnership
- ReMedi Health Solutions, Impact Advisors & Huron Deliver Strong Partnerships, with Isolated Variation in Client Satisfaction
- Key Considerations When Choosing an EHR Clinical Optimization Firm
- Common Drivers of Dissatisfaction & Best Practices to Avoid Pitfalls

Writer
Carlisa Cramer

Designer
Nikki Christensen

Project Manager
Sydney Toomer
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2025 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.